Amylyx Pharmaceuticals, Inc. (AMLX) Capital expenditures 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$138,000FY2025 · since FY2021: $353,000 → $138,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $138,000 | -12.1% |
| FY2024 | $157,000 | -87.3% |
| FY2023 | $1.2M | -50.9% |
| FY2022 | $2.5M | +615.6% |
| FY2021 | $353,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice